Hossein Jadvar1. 1. 1 Department of Radiology, Division of Nuclear Medicine, Keck School of Medicine, University of Southern California, 2250 Alcazar St, CSC Ste 102, Los Angeles, CA 90033.
Abstract
OBJECTIVE: This article reviews recent developments in targeted radionuclide therapy (TRT) approaches directed to malignant liver lesions, bone metastases, neuroendocrine tumors, and castrate-resistant metastatic prostate cancer and discusses challenges and opportunities in this field. CONCLUSION: TRT has been employed since the first radioiodine thyroid treatment almost 75 years ago. Progress in the understanding of the complex underlying biology of cancer and advances in radiochemistry science, multimodal imaging techniques including the concept of "see and treat" within the framework of theranostics, and universal traction with the notion of precision medicine have all contributed to a resurgence of TRT.
OBJECTIVE: This article reviews recent developments in targeted radionuclide therapy (TRT) approaches directed to malignant liver lesions, bone metastases, neuroendocrine tumors, and castrate-resistant metastatic prostate cancer and discusses challenges and opportunities in this field. CONCLUSION: TRT has been employed since the first radioiodine thyroid treatment almost 75 years ago. Progress in the understanding of the complex underlying biology of cancer and advances in radiochemistry science, multimodal imaging techniques including the concept of "see and treat" within the framework of theranostics, and universal traction with the notion of precision medicine have all contributed to a resurgence of TRT.
Authors: K J Paprottka; F Schoeppe; M Ingrisch; J Rübenthaler; N N Sommer; E De Toni; H Ilhan; M Zacherl; A Todica; P M Paprottka Journal: Eur J Nucl Med Mol Imaging Date: 2017-02-14 Impact factor: 9.236
Authors: Giuseppe Maria Ettorre; Giovanni Battista Levi Sandri; Andrea Laurenzi; Marco Colasanti; Roberto Luca Meniconi; Raffaella Lionetti; Roberto Santoro; Pasquale Lepiane; Rosa Sciuto; Giuseppe Pizzi; Roberto Cianni; Rita Golfieri; Gianpiero D'Offizi; Adriano M Pellicelli; Mario Antonini; Giovanni Vennarecci Journal: World J Surg Date: 2017-01 Impact factor: 3.352
Authors: Ana P Kiess; Il Minn; Ganesan Vaidyanathan; Robert F Hobbs; Anders Josefsson; Colette Shen; Mary Brummet; Ying Chen; Jaeyeon Choi; Eftychia Koumarianou; Kwamena Baidoo; Martin W Brechbiel; Ronnie C Mease; George Sgouros; Michael R Zalutsky; Martin G Pomper Journal: J Nucl Med Date: 2016-05-26 Impact factor: 10.057
Authors: Berthold A Nock; Aikaterini Kaloudi; Emmanouil Lymperis; Athina Giarika; Harshad R Kulkarni; Ingo Klette; Aviral Singh; Eric P Krenning; Marion de Jong; Theodosia Maina; Richard P Baum Journal: J Nucl Med Date: 2016-08-04 Impact factor: 10.057
Authors: Young Youn Cho; Minjong Lee; Hyo-Cheol Kim; Jin Wook Chung; Yun Hwan Kim; Geum-Youn Gwak; Si Hyun Bae; Do Young Kim; Jeong Heo; Yoon Jun Kim Journal: PLoS One Date: 2016-05-05 Impact factor: 3.240
Authors: Simon R Cherry; Terry Jones; Joel S Karp; Jinyi Qi; William W Moses; Ramsey D Badawi Journal: J Nucl Med Date: 2017-09-21 Impact factor: 10.057
Authors: Werner Hofmann; Wei Bo Li; Werner Friedland; Brian W Miller; Balázs Madas; Manuel Bardiès; Imre Balásházy Journal: Radiat Environ Biophys Date: 2019-12-21 Impact factor: 1.925